Adient (NYSE:ADNT – Get Free Report) had its price target cut by Barclays from $24.00 to $21.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price target indicates a potential upside of 24.53% from the stock’s previous close.
A number of other equities analysts have also commented on the stock. Wells Fargo & Company lowered shares of Adient from an “overweight” rating to an “equal weight” rating and lowered their price target for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Morgan Stanley lowered their price target on shares of Adient from $21.00 to $19.00 and set an “underweight” rating on the stock in a research report on Thursday, November 14th. StockNews.com raised shares of Adient from a “hold” rating to a “buy” rating in a research report on Saturday, December 28th. Finally, Bank of America lowered shares of Adient from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $30.00 to $24.00 in a research report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $23.13.
Get Our Latest Research Report on ADNT
Adient Stock Up 0.4 %
Adient (NYSE:ADNT – Get Free Report) last announced its quarterly earnings results on Friday, November 8th. The company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.12. The firm had revenue of $3.56 billion during the quarter, compared to analysts’ expectations of $3.47 billion. Adient had a net margin of 0.12% and a return on equity of 6.86%. The company’s revenue for the quarter was down 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.51 earnings per share. Analysts forecast that Adient will post 2.04 earnings per share for the current year.
Insider Activity
In other Adient news, EVP James Conklin sold 11,500 shares of the business’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total transaction of $232,875.00. Following the completion of the sale, the executive vice president now owns 51,829 shares in the company, valued at approximately $1,049,537.25. The trade was a 18.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is currently owned by company insiders.
Institutional Trading of Adient
Several institutional investors have recently made changes to their positions in the company. R Squared Ltd purchased a new position in shares of Adient in the 4th quarter worth about $32,000. US Bancorp DE boosted its holdings in shares of Adient by 583.8% in the 3rd quarter. US Bancorp DE now owns 1,860 shares of the company’s stock worth $42,000 after buying an additional 1,588 shares during the last quarter. Versant Capital Management Inc boosted its holdings in shares of Adient by 10,316.7% in the 4th quarter. Versant Capital Management Inc now owns 1,875 shares of the company’s stock worth $32,000 after buying an additional 1,857 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Adient by 493.8% in the 3rd quarter. Signaturefd LLC now owns 2,191 shares of the company’s stock worth $49,000 after buying an additional 1,822 shares during the last quarter. Finally, KBC Group NV boosted its holdings in shares of Adient by 51.8% in the 3rd quarter. KBC Group NV now owns 3,328 shares of the company’s stock worth $75,000 after buying an additional 1,136 shares during the last quarter. Institutional investors own 92.44% of the company’s stock.
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Featured Articles
- Five stocks we like better than Adient
- Comparing and Trading High PE Ratio Stocks
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Top Biotech Stocks: Exploring Innovation Opportunities
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is Short Interest? How to Use It
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.